Department of Prevention, Rehabilitation and Sports Medicine and Institute for Medical Statistics, Munich, Germany.
J Card Fail. 2009 May;15(4):334-40. doi: 10.1016/j.cardfail.2008.11.011. Epub 2009 Jan 9.
Distance walked in the 6-minute walk test (6MWT) is an important prognostic parameter used clinically to assess functional status in patients with chronic heart failure (CHF). In this study, we investigated if alternative performance parameters with similar prognostic value can be gained from accelerometers.
Fifty CHF patients (age, 60.9 +/- 14.0 years) were asked to perform a 6MWT while wearing 2 accelerometers and 1 pedometer. Total 6MWT step frequency (SF) and activity counts (VMU) were correlated to 6MWT distance. The accelerometer was highly accurate at quantifying SF (detected vs. observed: r = 0.99; P < .001), whereas the pedometer was unreliable below 50 m/min. VMU increased linearly with walking speed (r = 0.99), and both SF and VMU correlated strongly with 6MWT distance (VMU: r = 0.91; SF: r = 0.87, respectively; P < .001) and each other (r = 0.80, P < .001).
Accelerometers are reliable in measuring physical performance during the 6MWT in CHF patients. Besides the simple acquisition of 6MWT distance currently used for patient assessment, accelerometers provide new data that might be useful to evaluate exercise performance during the 6MWT. This allows for routine assessment of exercise capacity in a home-based setting in the context of telemedicine.
在 6 分钟步行测试(6MWT)中行走的距离是临床上用于评估慢性心力衰竭(CHF)患者功能状态的重要预后参数。在这项研究中,我们研究了是否可以从加速度计中获得具有相似预后价值的替代表现参数。
50 名 CHF 患者(年龄,60.9 +/- 14.0 岁)被要求在佩戴 2 个加速度计和 1 个计步器的情况下进行 6MWT。总 6MWT 步频(SF)和活动计数(VMU)与 6MWT 距离相关。加速度计在量化 SF 方面非常准确(检测与观察:r = 0.99;P <.001),而计步器在低于 50 m/min 时不可靠。VMU 随步行速度线性增加(r = 0.99),SF 和 VMU 与 6MWT 距离均呈强相关(VMU:r = 0.91;SF:r = 0.87,分别;P <.001),彼此之间也呈强相关(r = 0.80,P <.001)。
加速度计在测量 CHF 患者 6MWT 期间的身体表现方面非常可靠。除了目前用于评估患者的简单 6MWT 距离采集外,加速度计还提供了新的数据,这些数据可能有助于评估 6MWT 期间的运动表现。这允许在远程医疗背景下在家庭环境中常规评估运动能力。